Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared ...
WKRG on MSN
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results